The PennZone

  • Home
  • Entertainment
  • Marketing
  • Music
  • Non-profit
  • Books
  • Education
  • Automotive
  • Sports

SafeBreak® Vascular Cleared for Pediatrics
The PennZone/10232295

Trending...
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
  • LATO AI Automates Customer Communication to Help CSide Sports Academy and BAT 24 Nation Grow
  • LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - PennZone -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on The PennZone
  • Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
  • Imagen Golf Named Exclusive Golf Instruction Partner at Wood Lane Golf and Social
  • Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality
  • Heidi G. Villari of The Villari Firm, PLLC Recognized in The Best Lawyers in America 2027 for Construction Law and Personal Injury Litigation
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
  • CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards
  • NaturismRE expands international research programme with Health & Wellbeing Survey
  • L2 Aviation and Gotonomi Extend UAV Connectivity Beyond Cellular Reach
  • LATO AI Solidifies Future in Pittsburgh with North Shore Headquarters
  • Re:InvestorHub Launches the First AI-Powered Operating System Built for Real Estate Investors
  • Nadi Plumbing Leads Charlotte in Private Fire Hydrant Services, Eyes Regional Expansion
  • Obsolete Industrial Expands Its Membership
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
  • Four-Time Olympian Joetta Clark Diggs to Compete at World Masters Athletics Championships in Daegu
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
  • The Alistair Apartments Reaches 95% Occupancy in Downtown Lancaster, PA
  • Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
  • Where Do Missouri Plane Crashes Really Happen? Not Where You'd Think
  • LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
  • Kellyn Endorses National Push to Expand Food is Medicine
  • LATO AI Automates Customer Communication to Help CSide Sports Academy and BAT 24 Nation Grow

Popular on PennZone

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 793
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments - 112
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
  • Charmaine Thompson Turns Pain Into Purpose Through Woman of Power Charmcare
  • Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
  • $40 Billion Global Market Value by 2030 Projected in Unmanned Aerial Vehicle or Other Drone Technology Sector, Growing at 9.2% Compound Annual Growth
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • FDA Food Recall Notices After Outbreak Linked to 98 Hospitalizations: Practical Tips for Safer Grocery Shopping
  • Nola Blue Records Announces New Album from Sherman Holmes
  • Salestrics Introduces PraiseEngine: The AI-Native Review Engine Built to Fix Social Proof

Similar on PennZone

  • StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
  • Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • Nearly One-Third of CRE Asset Managers Make Major Capital Decisions on Gut Instinct, New Survey Finds
  • RemoteBridge Names Dr. John N. Just, Ed.D. Chief Executive Officer
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Revenue Optics Launches Pricing and Revenue Growth Management Practice, Names Shafohi Alamgir Vice President
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
  • CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards
  • NaturismRE expands international research programme with Health & Wellbeing Survey
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us